Integrating the Latest Data and
Guidelines in the Management of HIV: Strategies for Optimizing
Clinical and Economic Outcomes
A continuing medical education
activity provided by NAMCP and AAMCN
Novel Treatment Advances and Approaches in Management of HIV is a
three-part webinar series
This is Part 1 of the series focusing on the latest data and
guidelines in the management of HIV
This activity is an archive from the webinar held December 9, 2020
This activity is valid from January 1, 2021 to January 1, 2023
Instructions for CME/NCPD: Complete the pre-test, listen to the
audio and view the slides, complete the post test, complete the
evaluation form and hit submit. You will be asked to enter your name
and email address on the pre-test, evaluation and post-test. If you
close your internet browser without completing the post test, you
will have ONE more opportunity to complete. A score of 70% must be
achieved on the post test to receive continuing education credits.
If you do not pass the post test after two attempts, you will not be
eligible to try again. Once you complete the evaluation form and
score 70% or higher on your post test, you will automatically be
given your certificate.
To print or save your certificate, you will need to click on the
“download” button and either print or save.
This activity is intended for healthcare professionals practicing in
managed care environments.
This activity is supported by an
educational grant from
HIV is a lentivirus that causes HIV infection and over time acquired
immunodeficiency syndrome (AIDS). HIV infection leads to low levels
of CD4+ T cells through a number of specific mechanisms. When CD4+ T
cell numbers decline below a critical level, cell-mediated immunity
is lost, and the body becomes progressively more susceptible to
opportunistic infections. The CDC estimates that 1,218,400 people in
the US aged 13 years and older are living with HIV infection and an
estimated 6,955 people died in 2019. Fortunately, several new
therapies have become available recently, and more are set to become
Upon completion of this
activity, participants will be able to:
Examine the clinical burden of HIV,
including factors that contribute to poor prognosis and
Compare and contrast new and
emerging antiretroviral therapies (ART) based on the latest
evidence for their efficacy, safety, and adherence potential
Apply recent clinical trial data to
identify appropriate patient populations for new and emerging
2-drug regimens, including long-acting ART
Explore the role of newer therapies
for heavily treatment-experienced (HTE) adults with
multidrug-resistant HIV-1 infection
Evaluate patient-specific factors,
including age, comorbidities, concomitant medications, and
adherence challenges, in making decisions about HIV therapy
||Timothy J. Wilkin MD,
Associate Professor of Medicine
Weill Cornell Medical College
has received grants/research support from ViiV
Healthcare/GlaxoSmithKline and Merck. His presentation
has been peer reviewed for any bias.
MD has no real or perceived financial relationships to
Jeremy Williams has no real or perceived financial
relationships to disclose.
Jacqueline Cole, RN, MS, CMCN has no real or perceived
financial relationships to disclose.
NAMCP and/or the presenter
has copyright or has received permissions for use of
materials provided in this activity.
Accreditation & Designation
This activity has been planned and implemented in accordance with
the accreditation requirements and policies of the Accreditation
Council for Continuing Medical Education (ACCME) through the joint
providership of the National Association of Managed Care Physicians
(NAMCP) and American Association of Managed Care Nurses (AAMCN). The
National Association of Managed Care Physicians is accredited by the
ACCME to provide continuing medical education for physicians.
NAMCP designates this enduring material for a maximum of 1 AMA
PRA Category 1 credit(s)TM. Each
physician should claim credit commensurate with the extent of their
participation in the activity.
The American Association of Managed Care Nurses is accredited as a
provider of nursing continuing professional development by the
American Nurses Credentialing Center's Commission on Accreditation.
Nurses who complete this activity and achieve a passing score will
receive 1 hour in nursing continuing professional development.
This activity has been approved by the American Board of Managed
Care Nursing for 1.0 contact hours toward CMCN recertification
This activity is supported by an educational grant from
NAMCP and/or this website does not
provide medical advice, diagnosis or treatment. NAMCP does not
endorse or imply endorsement of the content on any linked website.
This website is to be used as an informational resource. With any
health related concern, consult with your physician or healthcare
Click Here To Continue